| Bioactivity | Exlinkibart (LVGN-6051) targets TNFRSF9 and is an IgG1κ antibody humanized through complementarity-determining region (CDR) grafting technology. |
| Target | 4-1BB/TNFRSF9 |
| Name | Exlinkibart |
| CAS | 2642171-64-8 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |